Evidence map›Paper›PMID 40108172›Full record

ArticleNature communications2025

A cysteine-less and ultra-fast split intein rationally engineered from being aggregation-prone to highly efficient in protein trans-splicing.

Christoph Humberg, Zahide Yilmaz, Katharina Fitzian, Wolfgang Dörner, Daniel Kümmel, Henning D Mootz

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christoph HumbergInstitute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.ORCID http://orcid.org/0000-0003-3394-9338
Zahide YilmazInstitute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.
Katharina FitzianInstitute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.ORCID http://orcid.org/0000-0002-9668-9919
Wolfgang DörnerInstitute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.ORCID http://orcid.org/0000-0001-7921-5765
Daniel KümmelInstitute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.ORCID http://orcid.org/0000-0003-3950-5914
Henning D MootzInstitute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany. Henning.Mootz@uni-muenster.de.ORCID http://orcid.org/0000-0002-3385-0234

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) MO1073/6-2Deutsche Forschungsgemeinschaft (German Research Foundation) MO1073/9-1
6 · The paper itself

Abstract

Split inteins catalyze protein trans-splicing by ligating their extein sequences while undergoing self-excision, enabling diverse protein modification applications. However, many purified split intein precursors exhibit partial or no splicing activity for unknown reasons. The Aes123 PolB1 intein, a representative of the rare cysteine-less split inteins, is of particular interest due to its resistance to oxidative conditions and orthogonality to thiol chemistries. In this work, we identify β-sheet-dominated aggregation of its N-terminal intein fragment as the origin of its low (~30%) splicing efficiency. Using computational, biochemical, and biophysical analyses, we characterize the fully active monomeric fraction and pinpoint aggregation-prone regions. Supported by a crystal structure, we design stably monomeric mutants with nearly complete splicing activity. The optimized CLm intein (Cysteine-Less and monomeric) retains the wild-type's ultra-fast reaction rate and serves as an efficient, thiol-independent protein modification tool. We find that other benchmark split inteins show similar precursor aggregation, suggesting that this general phenomenon arises from the intrinsic challenge to maintain the precursor in a partially disordered state while promoting stable folding upon fragment association.

Indexed as

CysteineInteinsProtein EngineeringProtein SplicingTrans-SplicingModels, MolecularProtein AggregatesCysteineProtein Aggregates

Identifiers

PMID40108172
PMCPMC11923092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.